Live Breaking News & Updates on Silvio inzucchi

Stay informed with the latest breaking news from Silvio inzucchi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Silvio inzucchi and stay connected to the pulse of your community

Discoveries & Impact (January 2023)

Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...

United-states , South-korea , Michigan , Han , American , Michael-chiorazzi , George-zhang , Rachelj-perry , Valeria-santini , Mikkaela-sekeres , Tarun-tyagi , Uwe-platzbecker

Drs. Moriarty and Inzucchi Receive Rosemarie L. Fisher, MD, Excellence in GME Awards

Two Department of Internal Medicine faculty are awardees of the Rosemarie L. Fisher, MD, Excellence in Graduate Medical Education Awards for 2022.

Vincent-quagliarello , Silvio-inzucchi , John-moriarty , Rosemariel-fisher , Stephenj-huot , Department-of-internal-medicine , Office-of-the-provost , Yale-school-of-medicine , Medicine-primary-care-residency-program , Hospitals-program , Diabetes-center , Harvard-medical-school

Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease

Yale Endocrinology Obesity Medicine is a multidisciplinary program.

United-states , Westport , Connecticut , North-haven , American , Howard-forman , Wendy-silverman , John-morton , Harlan-krumholz , Rajita-sinha , Silvio-inzucchi , Wajahat-mehal

Yale Endocrinology Obesity Medicine: Approaching Obesity as a Complex, Chronic Disease

Yale Endocrinology Obesity Medicine is a multidisciplinary program.

United-states , Westport , Connecticut , North-haven , American , Howard-forman , Wendy-silverman , John-morton , Harlan-krumholz , Rajita-sinha , Silvio-inzucchi , Wajahat-mehal

Episode 4: Better Ways to Sustain Weight Loss in Type 2 Diabetes

Patients with type 2 diabetes and obesity have more options today than ever before. Join host Dr Silvio Inzucchi and obesity expert Dr Ania Jastreboff as they discuss ways to support weight loss.

Silvio-inzucchi , Ania-jastreboff , Medscape-indiscussion , Yale-stress-center , Yale-school-of-medicine , Endocrine-society , Im-dr-silvio-inzucchi , Yale-school , Yale-weight-management , Obesity-prevention , Yale-stress

Episode 3: How to Reduce Renal Risk in Type 2 Diabetes

Want to prevent kidney disease progression in patients with type 2 diabetes? Join host Dr Silvio Inzucchi and nephrologist Dr David Cherney as they unpack the how and why behind current recommendations.

United-states , Canada , Toronto , Ontario , American , Silvio-inzucchi , Medscape-indiscussion , Kathy-tuttle , David-cherney , Hospital-research-institute , University-of-toronto , University-health-network

Episode 2: A Brave New World in Type 2 Diabetes Treatment and Beyond

Where are the biggest cardiovascular benefits for your patients with type 2 diabetes? Host Silvio Inzucchi and cardiologist Mikhail Kosiborod reveal winning strategies -- for managing much more than just type 2 diabetes.

United-states , Russia , Missouri , University-of-missouri , Soviet , American , Darren-mcguire , Silvio-inzucchi , Medscape-indiscussion , Mikhail-kosiborod , Luke-mid-america-heart-institute , International-diabetes-guidelines

SGLT2 Inhibitors in Primary Care: 'All Hands on Deck'

SGLT2 Inhibitors in Primary Care: 'All Hands on Deck'
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Yale-university , Connecticut , United-states , New-haven , Georgetown-university , District-of-columbia , Washington , Silvio-inzucchi , Mikhail-kosiborod , Kenny-lin , University-of-missouri , Georgetown-university-school-of-medicine

Which Patients With Type 2 Diabetes Need SGLT2 Inhibitors?

With an essential role established for SGLT2 inhibitors for patients with progressive renal dysfunction or heart failure, researchers discuss how best to use these agents in those with type 2 diabetes.

Boston , Massachusetts , United-states , California , Dallas , Texas , University-of-texas-southwestern-medical-center , Toronto , Ontario , Canada , America , Aliceyy-cheng

Earlier Diabetes Onset Could Raise Dementia Risk

Earlier Diabetes Onset Could Raise Dementia Risk
The younger the age at diagnosis for Type 2 diabetes, the higher the risk for Alzheimer’s disease and other forms of dementia years later.
Credit...Paper Illustration by Reina Takahashi, photographed by Tony Cenicola/The New York Times
May 3, 2021, 5:00 a.m. ET
Type 2 diabetes is a chronic, progressive illness that can have devastating complications, including hearing loss, blindness, heart disease, stroke, kidney failure and vascular damage so severe as to require limb amputation. Now a new study underscores the toll that diabetes may take on the brain. It found that Type 2 diabetes is linked to an increased risk for Alzheimer’s disease and other forms of dementia later in life, and the younger the age at which diabetes is diagnosed, the greater the risk.

United-states , United-kingdom , American , British , Silvio-inzucchi , Centers-for-disease , Yale-diabetes-center , Disease-control , Diabetes , Alzheimer-x27-s , Dementia , Obesity